未登录.png)
分享.png)
收藏分享 收藏 Functionalized Lignin Enables Co-Cross-Linking of Natural Rubber and Simultaneous Carbon Black Dispersion
Hu, Yan-Ping; Liu, Jing-Yan; Jiang, Xin-Li; Hou, De-Fa; Lin, Xu; Zheng, Yun-Wu; Yang, Fu-Lin; Zou, Yuan; Sun, Hao; Yang, Long; Liu, Can; Du, Guan-Ben 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trialfinotonlimab联合多西他赛对比多西他赛治疗既往经治的晚期鳞状细胞非小细胞肺癌的疗效与安全性：一项随机、双盲、III期临床试验Han, Baohui; Wu, Lin; Yang, Runxiang; Wu, Hongbo; Li, Wei; Yu, Yan; Zhang, Mingjuan; Sun, Hongmei; Chu, Tianqing; Zhong, Fukuan; Fang, Yong; Wu, Rong; Bian, Tao; Guo, Xiaoqing; Sun, Meili; Zhang, Yanming; Liu, Lianke; Liu, Xuewen; Pan, Yueyin; Jiang, Ou; Wei, Zonghui; Lin, Haifeng; Guo, Wei; Fang, Jian; Wang, Jialei; Ding, Cuimin; Hu, Yanping; Ye, Feng; Zhuang, Wu; Ye, Shucheng; Wang, Lihong; Huang, Zhe; Liu, Chang; Yang, Ling; Wang, Jinling; Xie, Liangzhi 分享 收藏 The value of serum tumor-associated autoantibodies in screening and diagnosis of gastric cancerXiao, Kangjia; Xie, Chengxuan; Zhang, Yi; Kang, Meihua; Wang, Yanchun; Li, Qingtian; Dong, Wenqian; Wang, Hao; Wei, Huaxing; Hu, Yanping; Wang, Baolong; Lu, Renquan 分享 收藏 A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001)一项安罗替尼联合EGFR-TKIs治疗EGFR-TKIs治疗后出现渐进性、寡性或潜在性进展的晚期非小细胞肺癌的II期临床试验（CTONG-1803/ALTER-L001）。Chen, Hua-Jun; Tu, Hai-Yan; Hu, Yanping; Fan, Yun; Wu, Guowu; Cang, Shundong; Yang, Yi; Yang, Nong; Ma, Rui; Jin, Gaowa; Xu, Ximing; Liu, Anwen; Tang, Shubin; Cheng, Ying; Yu, Yan; Xu, Chong-Rui; Zhou, Qing; Wu, Yi-Long 分享 收藏 A phase II study of Becotatug (JMT101) in combination with osimertinib (Osi) in patients (pts) with classical EGFR-mutated non-small cell lung cancer (NSCLC) (BOOSTER Study)一项Becotatug（JMT101）联合奥希替尼（Osi）治疗经典EGFR突变非小细胞肺癌（NSCLC）患者的II期研究（BOOSTER研究）Zhang, L.; Fang, W. F.; Zhao, S.; Yu, Y.; Yong, T. X.; Dong, X.; Zhuang, W.; Hu, Y.; Luo, F.; Wang, Q.; Chu, Q.; Fu, Z.; Yao, Y.; Ma, X.; Ding, C.; Hao, J.; Yang, X.; Wan, X.; Li, M.; Yang, Y. 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Exploratory biomarker analysis of phase III ASTRUM-004 study: Serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancerIII期ASTRUM-004研究探索性生物标志物分析：Serplulimab联合化疗作为晚期鳞状非小细胞肺癌的一线治疗Zhou, C.; Hu, Y.; Arkania, E.; Kilickap, S.; Ying, K.; Xu, F.; Wu, L.; Wang, X.; Viguro, M.; Makharadze, T.; Guo, L.; Yang, F.; Liu, Y.; Yang, X.; Zhong, S.; Wang, Q.; Li, J.; Shan, Y.; Zhu, J. 分享 收藏 Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 studyYang, Jin-Ji; Zhou, Jianying; Liu, Si-Yang Maggie; Li, Mingjun; Zhang, Zhiye; Cheng, Ying; Fan, Yun; Pan, Hongming; Wang, Baoqing; Chen, Gongyan; Wang, Ke; Jiang, Liyan; Hu, Yanping; Shi, Jianhua; Dong, Xiaorong; Ding, Cuimin; Liu, Yunpeng; Liu, Zhe; Liao, Wangjun; Li, Wei; Wang, Jun; Yi, Shanyong; Zhao, Qiong; Zang, Aimin; Chen, Yuan; Cui, Jiuwei; Luo, Pengfei; Shen, Xionghu; Sun, Meili; Wang, Changli; Wu, Yi-Long 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
